These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 30859224)

  • 1. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
    Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
    Carcinogenesis; 2019 Mar; 40(1):202. PubMed ID: 30859224
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
    Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
    Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
    Kirschner AN; Wang J; van der Meer R; Anderson PD; Franco-Coronel OE; Kushner MH; Everett JH; Hameed O; Keeton EK; Ahdesmaki M; Grosskurth SE; Huszar D; Abdulkadir SA
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.
    Wen Y; An Z; Qiao B; Zhang C; Zhang Z
    Urol Oncol; 2019 May; 37(5):297.e1-297.e7. PubMed ID: 30737160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
    Holder SL; Abdulkadir SA
    Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
    Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
    Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
    Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
    Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
    Zippo A; De Robertis A; Serafini R; Oliviero S
    Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells.
    van der Poel HG; Zevenhoven J; Bergman AM
    Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
    Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
    Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional SUMO-motif in the active site of PIM1 promotes its degradation via RNF4, and stimulates protein kinase activity.
    Iyer RS; Chatham L; Sleigh R; Meek DW
    Sci Rep; 2017 Jun; 7(1):3598. PubMed ID: 28620180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells.
    Kim O; Jiang T; Xie Y; Guo Z; Chen H; Qiu Y
    Oncogene; 2004 Mar; 23(10):1838-44. PubMed ID: 14981536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis.
    Zhang W; Tong D; Liu F; Li D; Li J; Cheng X; Wang Z
    Oncotarget; 2016 Feb; 7(5):5800-14. PubMed ID: 26735579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction.
    Ye C; Zhang C; Huang H; Yang B; Xiao G; Kong D; Tian Q; Song Q; Song Y; Tan H; Wang Y; Zhou T; Zi X; Sun Y
    Cell Physiol Biochem; 2018; 48(3):1230-1244. PubMed ID: 30045021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of quinones as novel PIM1 kinase inhibitors.
    Schroeder RL; Goyal N; Bratton M; Townley I; Pham NA; Tram P; Stone T; Geathers J; Nguyen K; Sridhar J
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3187-3191. PubMed ID: 27173800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
    Bouquet C; Melchers F
    Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
    An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
    Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
    Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
    Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
    Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
    Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.